Illness Identity in Inflammatory Bowel Disease
Tóm tắt
We examined the degree to which adults with inflammatory bowel disease (IBD) integrated their illness into their identity and linked illness identity to important patient-reported outcomes. A total of 109 adults with IBD, aged 18 to 60 (Mage = 35.93; 77% women) completed questionnaires on the four illness identity dimensions (rejection, acceptance, engulfment, and enrichment), medication adherence, depressive symptoms, life satisfaction, health status, and health-related quality of life (HRQoL). The illness identity scores of adults with IBD were compared to existing data from adults with congenital heart disease (CHD), refractory epilepsy (RE), and multisystemic connective tissue disorders (MSDs) using multivariate analyses of covariance. In adults with IBD, associations between illness identity and patient-reported outcomes were examined through hierarchical regression analyses, controlling for sex, age, illness duration, diagnosis, self-reported flares, and co-existing illnesses. Adults with IBD scored higher on rejection and engulfment and lower on acceptance than adults with CHD, lower on rejection but higher on engulfment than adults with RE, and higher on engulfment and enrichment but lower on rejection than adults with MSDs. Higher engulfment scores were related to more depressive symptoms, lower life satisfaction, and a poorer health status and HRQoL. In contrast, higher enrichment scores were related to more life satisfaction and a better HRQoL. Rejection and acceptance were not uniquely related to any of the outcomes. Adults with IBD showed relatively high levels of engulfment. Substantial associations were observed between illness identity and patient-reported outcomes, with engulfment being the strongest, most consistent predictor.
Tài liệu tham khảo
Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analysis — part I. Inflamm Bowel Dis. 2018;24:742–50.
Neuendorf R, Harding A, Stello N, Hanes D, Wahbehab H. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70–80.
Navabi S, Gorrepati VS, Yadav S, et al. Influences and impact of anxiety and depression in the setting of inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:2303–8.
Shah NB, Haydek J, Slaughter J, et al. Risk factors for medication nonadherence to self-injectable biological therapy in adult patients with inflammatory bowel disease. Inflamm Bowel Dis. 2020;26:314–20.
Govani SM, Noureldin M, Higgins PDR, et al. Defining an optimal adherence threshold for patients taking subcutaneous anti-TNFs for inflammatory bowel diseases. Am J Gastroenterol. 2018;113:276–82.
Greenley RN, Hommel KA, Nebel J, et al. A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol. 2010;35:857–69.
Ruana J, Zhoua Y. Regaining normality: a grounded theory study of the illness experiences of Chinese patients living with Crohn’s disease. Int J Nurs Stud. 2019;93:87–96.
Charmaz K. The body, identity, and self. Sociol Quart. 1995;36:657–80.
Oris L, Rassart J, Prikken S, et al. Illness identity in adolescents and emerging adults with type 1 diabetes: introducing the Illness Identity Questionnaire. Diabetes Care. 2016;39:757–63.
Oris L, Luyckx K, Rassart J, et al. Illness identity in adults with a chronic illness. J Clin Psychol Med Settings. 2018;25:429–40.
Morea JM, Friend R, Bennett RM. Conceptualizing and measuring illness self-concept: a comparison with self-esteem and optimism in predicting fibromyalgia adjustment. Res Nurs Health. 2008;31:563–75.
Guo L, Rohde J, Farraye FA. Stigma and disclosure in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2020;26:1010–6.
Taft T, Keefer K, Leonhard C, Nealon-Woods M. Impact of perceived stigma on inflammatory bowel disease patient outcomes. Inflamm Bowel Dis. 2009;15:1224–32.
Sirois FM, Hirsch JK. A longitudinal study of the profiles of psychological thriving, resilience, and loss in people with inflammatory bowel disease. Br J Health Psychol. 2017;22:920–39.
Wynne B, McHugh L, Gao W. Acceptance and commitment therapy reduces psychological stress in patients with inflammatory bowel diseases. Gastroenterology. 2019;156:935–45.
Tran V, Wiebe DJ, Fortenberry KT, Butler JM, Berg CA. Benefit finding, affective reactions to diabetes stress, and diabetes management among early adolescents. Health Psychol. 2011;30:212–9.
Luyckx K, Oris L, Raymaekers K, et al. Illness identity in young adults with refractory epilepsy. Epilepsy Behav. 2018;80:48–55.
Knödler LL, Thomann PA, Ebert MP. The concept of illness identity in inflammatory bowel disease. J Crohns Colitis. 2020;S414-S415.
Quintas R, Raggi A, Giovannetti AM, et al. Psychosocial difficulties in people with epilepsy: a systematic review of literature from 2005 until 2010. Epilepsy Behav. 2012;25:60–7.
Arat S, Rassart J, Moons P, Luyckx K, Vandenberghe J, Westhovens R. Prospective associations between illness perceptions and health outcomes in patients with systemic sclerosis and systemic lupus erythematosus: a cross-lagged analysis. Rheumatol Adv Pract. 2018;2:rky007.
Jackson JL, Gerardo GM, Daniels CJ, Vannatta K. Perceptions of disease-related stress: a key to better understanding patient-reported outcomes among survivors of congenital heart disease. J Cardiovasc Nurs. 2017;32:587–93.
Rassart J, Oris L, Prikken S, et al. Illness identity and adjusting to type 1 diabetes: a four-wave longitudinal study. Health Psychol. 2021; in press.
Ho PYM, Hu W, Lee YY, et al. Health-related quality of life of patients with inflammatory bowel disease in Singapore. Intest Res. 2019;17:107–18.
Kline RB. Principles and practice of structural equation modeling. New York, NY: Guilford Press; 2015.
Tommelein E, Mehuys E, Van Tongelen I, Brusselle G, Boussery K. Accuracy of the Medication Adherence Report Scale (MARS-5) as a quantitative measure of adherence to inhalation medication in patients with COPD. Ann Pharmacother. 2014;48:589–95.
Selinger CP, Ochieng AO, George V, Leong RW. The accuracy of adherence self-report scales in patients on thiopurines for inflammatory bowel disease: a comparison with drug metabolite levels and medication possession ratios. Inflamm Bowel Dis. 2019;25:919–24.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiat Scand. 1983;67:361–70.
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52:69–77.
Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985;49:71–5.
Pavot W, Diener E. Review of the Satisfaction With Life Scale. In: Diener E (Ed). Social indicators research series: Vol. 39. Assessing well-being: the collected works of Ed Diener. Springer Science + Business Media. 2009:101–17.
EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
Moons P, Van Deyk K, De Bleser L, et al. Quality of life and health status in adults with congenital heart disease: a direct comparison with healthy counterparts. Eur J Cardiovasc Prev Rehabil. 2006;13:407–13.
Irvine EJ, Zhou Q, Thompson AK. The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol. 1996;91:1571–8.
Chen XL, Zhong LH, Wen Y, et al. Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties. Health Qual Life Outcomes. 2017;15:177.
Benjamini Y, Hochberg Y. Controlling the false discovery rate—a practical and powerful approach to multiple testing. J R Stat Soc Ser B-Method. 1995;57:289–300.
Goshtasbi K, Abouzari M, Djalilian HR. Are acoustic neuroma association patients characteristically different than the general population patients? The benefits and drawbacks of survey-based studies. Otol Neurotol. 2019;40:979–80.
Sándor Z, Látos M, Pócza-Vége P, Havancsák R, Csabai M. The drawing version of the pictorial representation of illness and self-measure. Psychol Health. 2020;35:1033–48.
Jordan C, Hayee B, Chalder T. Cognitive behaviour therapy for distress in people with inflammatory bowel disease: a benchmarking study. Clin Psychol Psychother. 2019;26:14.
Leone D, Gilardi D, Corro BE, et al. Psychological characteristics of inflammatory bowel disease: a comparison between active and nonactive patients. Inflamm Bowel Dis. 2019;25:1399–407.